BioSig Technologies, Inc. STEX Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable And Accrued Expenses
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable And Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by BioSig Technologies, Inc. in its filing.
Tagged under the XBRL concept STEX:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAndAccruedExpenses.
The official record: BioSig Technologies, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioSig Technologies, Inc.'s business combination recognized identifiable assets acquired and liabilities assumed current liabilities accounts payable and accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioSig Technologies, Inc.'s business combination recognized identifiable assets acquired and liabilities assumed current liabilities accounts payable and accrued expenses?
- BioSig Technologies, Inc. (STEX) reported business combination recognized identifiable assets acquired and liabilities assumed current liabilities accounts payable and accrued expenses of $262K in Q2 2025.
- What does business combination recognized identifiable assets acquired and liabilities assumed current liabilities accounts payable and accrued expenses mean?
- This metric captures the fair value of accounts payable and accrued expenses assumed from an acquired entity at the time of the business combination. It represents the short-term liabilities the company has taken on as part of the acquisition integration process.